Key Financials Snapshot

TTM · Standalone · ₹ in Cr
Market Cap
₹37 Cr.
Stock P/E
-5.8
P/B
0.4
Current Price
₹0.4
Book Value
₹ 1
Face Value
1
52W High
₹0.9
52W Low
₹ 0.3
Dividend Yield
0%

Rajnish Wellness Overview

Business

Rajnish Wellness Ltd. is an Indian company primarily engaged in the manufacturing, marketing, and distribution of Ayurvedic medicinal products, sexual wellness products, and personal care items. The company operates on a business-to-consumer (B2C) model, developing proprietary Ayurvedic formulations and marketing them extensively through various media channels, including television, print, and digital platforms. Its core strategy involves direct outreach to consumers and building brand recognition in specific wellness niches to generate revenue from product sales.

Revenue Mix

The company's product portfolio is broadly categorized into:

Sexual Wellness: This segment includes products designed to address various sexual health concerns, with "Playwin" being a prominent brand.

Pain Relief: Ayurvedic solutions for pain management, featuring brands such as "Rajmay" and "Rajnish Lotion."

General Wellness & Personal Care: Other health and personal care products.

While specific revenue contributions per segment are not typically disclosed in granular detail for the public, the sexual wellness segment, particularly through its "Playwin" brand, is understood to be a significant contributor to the company's overall revenue due to its focused and extensive marketing efforts.

Industry

Rajnish Wellness operates within the highly competitive and growing Indian Ayurvedic and wellness products industry. This industry is characterized by the presence of large, established players (e.g., Dabur, Patanjali, Himalaya), numerous smaller regional brands, and a rising consumer preference for natural and herbal solutions. Rajnish Wellness positions itself as a niche player, specifically targeting segments like sexual wellness and focused pain relief, aiming to carve out market share through aggressive advertising and direct consumer engagement rather than competing across a broad range of general wellness products.

MOAT

Rajnish Wellness possesses a limited competitive moat. Its primary advantages include:

Niche Brand Recognition: Through consistent and prominent advertising, particularly for its "Playwin" brand, the company has built a degree of brand recall and loyalty within its specific sexual wellness segment.

Proprietary Formulations: The company's Ayurvedic formulations, while based on traditional knowledge, are proprietary, offering some product differentiation.

However, these advantages are vulnerable to intense competition from larger players with deeper pockets, the emergence of generic alternatives, and new entrants into similar niche markets.

Growth Drivers

Key factors that can drive growth for Rajnish Wellness over the next 3-5 years include:

Growing Indian Wellness Market: Increasing health consciousness and a rising demand for Ayurvedic and herbal products across India.

Digital Penetration and E-commerce: Expanding reach and direct-to-consumer engagement through online platforms and digital marketing strategies.

New Product Development: Introduction of new products or line extensions into adjacent wellness and personal care categories.

Distribution Expansion: Deepening its retail distribution network in existing markets and exploring opportunities in new geographies.

Continued Brand Building: Sustained investment in advertising and promotional activities to enhance brand loyalty and awareness within its focused segments.

Risks

Intense Competition: Facing significant competition from both well-established domestic and international players, as well as numerous regional and unorganized sector participants.

High Marketing Costs: The company's strategy relies heavily on advertising, leading to substantial and ongoing marketing expenditures that can pressure profitability.

Regulatory Scrutiny: Ayurvedic product claims can be subject to stringent regulatory oversight and potential challenges regarding efficacy, safety, and advertising standards.

Product Efficacy & Perception: Risks related to consumer perception of product effectiveness, potential for negative publicity, or legal challenges regarding product claims.

Raw Material Price Volatility: Fluctuations in the cost and availability of key herbal raw materials can impact production costs and margins.

Brand Dilution: Challenges in maintaining a strong brand identity if the company attempts to diversify too broadly across product categories.

Management & Ownership

The company is promoted by Mr. Rajnish Kumar Singh, who serves as the Chairman & Managing Director, and Mrs. Sanjana Singh. Mr. Rajnish Kumar Singh has been instrumental in the company's strategic direction, particularly its marketing and brand-building initiatives. The promoter group typically holds a significant stake in the company, aligning their interests with the company's performance, alongside public shareholding.

Outlook

Rajnish Wellness operates within a high-growth segment of the Indian wellness market, benefiting from increasing consumer preference for natural products and expanding digital reach. The company's focused brand-building efforts in specific niche segments, particularly sexual wellness, provide a foundation for potential market share gains. However, sustaining growth and profitability will be contingent on its ability to effectively manage intense competition, control significant marketing expenses, and navigate potential regulatory challenges related to product claims and advertising. Its future trajectory will be determined by successful new product development, continued strategic brand investment, and prudent expansion strategies while maintaining compliance and consumer trust.

Rajnish Wellness Share Price

Live · BSE · Inception: 2015
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Standalone · annual

Rajnish Wellness Quarterly Results

#(Fig in Cr.) Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 27 16 17 9 6 5 12 23 102 31
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 27 17 17 9 6 5 12 24 102 31
Total Expenditure 26 16 17 9 6 4 12 25 109 31
Operating Profit 1 0 0 0 -0 0 0 -1 -7 0
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 0 0 0 0 -0 0 0 -1 -7 0
Provision for Tax 0 0 0 0 0 0 0 -0 -2 0
Profit After Tax 0 0 0 0 -0 0 0 -1 -5 0
Adjustments 0 0 -0 -0 0 0 0 -0 0 0
Profit After Adjustments 0 0 0 0 -0 0 0 -1 -5 0
Adjusted Earnings Per Share 0 0 0 0 -0 0 0 -0 -0 0

Rajnish Wellness Profit & Loss

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Net Sales 13 25 27 42 14 13 26 26 77 49 142 168
Other Income 0 0 1 0 0 4 1 2 0 1 1 0
Total Income 13 25 29 42 14 17 27 28 77 49 143 169
Total Expenditure 13 24 24 35 14 17 27 27 75 49 151 177
Operating Profit 0 1 4 7 0 0 1 1 2 1 -8 -8
Interest 0 0 1 1 1 0 0 0 1 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 0 1 4 6 -1 0 1 1 1 0 -8 -8
Provision for Tax 0 0 1 2 -0 0 0 0 0 0 -2 -2
Profit After Tax 0 1 2 4 -1 0 0 0 1 0 -6 -6
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 0 1 2 4 -1 0 0 0 1 0 -6 -6
Adjusted Earnings Per Share 0 0.1 0.1 0.1 -0 0 0 0 0 0 -0.1 0

Rajnish Wellness Balance Sheet

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Shareholder's Funds 0 1 6 22 22 22 22 83 84 84 103
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 0 1 2 1 6 6 7 10 4 0 0
Other Non-Current Liabilities -0 0 -0 -0 -0 -0 -0 -0 2 2 0
Total Current Liabilities 5 6 10 9 6 7 6 6 17 4 3
Total Liabilities 5 8 18 32 33 34 35 99 106 91 106
Fixed Assets 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 1 1 1 61 25 16 23
Total Current Assets 5 8 17 31 32 33 34 38 81 75 84
Total Assets 5 8 18 32 33 34 35 99 106 91 106

Rajnish Wellness Cash Flow

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Opening Cash & Cash Equivalents 0 1 0 0 2 0 0 1 0 0 0
Cash Flow from Operating Activities 1 -2 -3 -9 -7 0 -0 -62 2 -4 -9
Cash Flow from Investing Activities -0 -0 -0 -0 -0 0 -0 -0 -0 9 -7
Cash Flow from Financing Activities 0 1 3 10 5 -0 1 62 -2 -5 25
Net Cash Inflow / Outflow 1 -0 -0 1 -1 0 1 -1 -0 0 9
Closing Cash & Cash Equivalent 1 0 0 2 0 0 1 0 0 0 10

Rajnish Wellness Ratios

# Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Earnings Per Share (Rs) 0.05 0.1 0.11 0.14 -0.02 0 0.01 0.01 0.01 0 -0.06
CEPS(Rs) 0.05 0.1 0.11 0.14 -0.02 0 0.01 0.01 0.01 0 -0.06
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 0.06 0.15 0.27 0.72 0.7 0.7 0.72 1.1 1.11 1.12 1.01
Core EBITDA Margin(%) 3.64 4.65 12 15.64 0.98 -23.73 -0.36 -4.3 2.6 0.01 -6.5
EBIT Margin(%) 3.62 4.61 16 16.2 1.98 3.14 3.15 2.59 2.57 1.04 -5.93
Pre Tax Margin(%) 3.62 3.75 13.23 14.09 -4.49 0.87 2.08 2.45 1.89 0.48 -5.94
PAT Margin (%) 2.46 2.53 8.85 10.16 -4.43 0.75 1.48 1.78 1.35 0.36 -4.44
Cash Profit Margin (%) 2.48 2.57 9.04 10.32 -4.04 1.16 1.51 1.83 1.38 0.41 -4.42
ROA(%) 6.1 9.34 18.74 17.18 -1.88 0.29 1.13 0.69 1.01 0.18 -6.36
ROE(%) 86.61 92.18 69.21 29.97 -2.78 0.46 1.79 0.88 1.24 0.21 -6.74
ROCE(%) 42.23 47.77 64.81 36.75 0.97 1.4 2.71 1.08 2.17 0.59 -9
Receivable days 57.1 44.47 118.1 141.95 407.72 393.83 227.79 257.12 128.14 226.77 59.22
Inventory Days 69.19 43.42 37.46 22.17 52.81 29.23 22.06 41.29 30.97 71.93 29.64
Payable days 233.31 92.75 122.38 67.79 51.68 39.84 24.5 36.48 47.74 75.48 8.58
PER(x) 0 0 0 16.11 0 51.68 220.44 2711.33 473.72 400 0
Price/Book(x) 0 0 0 3.07 0.4 0.24 3.91 15.09 5.83 0.82 0.4
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0.02 0.1 0.26 1.75 1.19 1.03 3.64 49.78 6.56 1.45 0.22
EV/Core EBITDA(x) 0.48 2.22 1.59 10.68 50.3 28.9 114.66 1884.64 252.5 132.78 -3.72
Net Sales Growth(%) 0 92.23 8.7 51.54 -67.01 -2.95 98.16 -2.31 196.93 -36.67 191.91
EBIT Growth(%) 0 144.94 277.55 53.39 -95.97 54.14 98.76 -19.65 194.16 -74.27 -1758.95
PAT Growth(%) 0 97.43 281.07 74 -114.37 116.38 293.18 17.37 124.56 -83.26 -3734.22
EPS Growth(%) 0 97.43 11.67 27.04 -114.37 116.38 293.18 -51.71 123.77 -83.21 -2791.3
Debt/Equity(x) 2.02 2.71 0.63 0.21 0.36 0.4 0.41 0.12 0.06 0 0
Current Ratio(x) 1.07 1.37 1.82 3.51 5.48 4.9 5.81 6.58 4.86 16.78 25.13
Quick Ratio(x) 0.56 0.79 1.6 3.18 5.3 4.74 5.46 5.92 4.3 14.58 21.18
Interest Cover(x) 0 5.4 5.77 7.69 0.31 1.38 2.93 18 3.76 1.85 -1828.09
Total Debt/Mcap(x) 0 0 0 0.07 0.89 1.64 0.1 0.01 0.01 0 0

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +190% +76% +61% +27%
Operating Profit CAGR -900% 0% — —
PAT CAGR — — — —
Share Price CAGR -58% -69% -29% —
ROE Average -7% -2% -1% +25%
ROCE Average -9% -2% 0% +17%

Rajnish Wellness Shareholding Pattern

Latest · Jun 2026
100% held
Promoters 9.16 %
FII 0.43 %
DII (MF + Insurance) 0 %
Public (retail) 90.41 %
# Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Promoter 16.2416.2416.247.417.417.419.169.169.169.16
FII 1.091.20.200.570.570.430.430.430.43
DII 0000000000
Public 82.6782.5683.5792.5992.0292.0290.4190.4190.4190.41
Others 0000000000
Total 100100100100100100100100100100

Rajnish Wellness Peer Comparison

Rajnish Wellness Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Rajnish Wellness Pros & Cons

Pros

  • Stock is trading at 0.4 times its book value
  • Debtor days have improved from 75.48 to 8.58days.
  • Company is almost debt free.

Cons

  • Promoter holding is low: 9.16%.
  • Company has a low return on equity of -2% over the last 3 years.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp